Table 2 Effects of BL EVO on plasmatic biomarkers in both healthy postmenopausal women and breast cancer patients
From: Nutrition, aging and cancer: lessons from dietary intervention studies
Variable | Baseline | After | p-valuea |
|---|---|---|---|
Azotemia | 30.85 | 28.48 | 0.002 |
Uricemia | 4.17 | 4.29 | 0.001 |
Glycemia | 85.35 | 83.59 | 0.021 |
Insulinemia | 10.33 | 8.79 | <0.001 |
Total cholesterol | 207.48 | 197.12 | <0.001 |
Gamma GT | 21.90 | 24.50 | 0.001 |
Total Proteinemia | 7.00 | 6.91 | 0.005 |
Sideremia | 76.95 | 67.02 | <0.001 |